Daiichi Sankyo Co Ltd. Posts $3.7 Billion Q3 Loss on Ranbaxy Pharmaceuticals Inc.

January 30, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO, Jan 30 (Reuters) - Daiichi Sankyo, Japan's third-largest drugmaker, posted a $3.7 billion quarterly loss and forecast its first annual loss, hit by a slide in the value of its stake in India's Ranbaxy Laboratories.

Twitter
LinkedIn
Facebook
Email
Print

Earnings Asia

Daiichi Sankyo